Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Thyroid Disorders
Do you recommend low dose RAI ablation for low risk papillary thyroid cancer with lymphatic invasion alone (no angio-invasion or known nodal involvement)?
Answer from: at Community Practice
No. Unless other factors, such as grossly positive margins.
Sign In
or
Register
to read more
26899
Related Questions
For patients with low risk, differentiated thyroid cancer, how do you navigate the decision between less aggressive treatments, such as lobectomy alone without radioactive iodine, and more aggressive strategies?
What is the role of metformin in treating Hashimoto's disease?
Is it safe to discontinue prenatal vitamins that contain biotin for a few days during pregnancy when labs in particular thyroid tests are planned for treating hypo or hyperthyroidism in pregnancy?
Would you consider extending Tepezza treatment for thyroid eye disease management in patients with incomplete response?
Is there a role for adding methotrexate to methimazole in the treatment of Graves' disease?
Statistically speaking, approximately what percentage of thyroid nodule FNA biopsies are Bethesda category 1 (= nondiagnostic or unsatisfactory), and what percentage are indeterminate (Bethesda category 3 and 4)?
Would you start low dose methimazole therapy in patients with positive TRAb, normal FT4 and FT3 levels but ongoing TSH suppression in a completely asymptomatic young patient?
What doses of methimazole do you consider "low dose" when treating Graves' disease long-term?
For patients on T4/T3 combination therapy for management of hypothyroidism is there an indication for monitoring T3 levels and if so, what is the appropriate timing (trough versus peak) given the pharmacokinetics of liothyronine?
How do you determine when to treat versus monitor subclinical thyroid disease early in pregnancy in patients with a negative TPOAb?